Eliopoulos AG - Search Results

1

Inhibition of human breast carcinoma growth by a soluble recombinant human CD40 ligand.

Hirano A, Longo DL, Taub DD, Ferris DK, Young LS, Eliopoulos AG, Agathanggelou A, Cullen N, Macartney J, Fanslow WC, Murphy WJ. Hirano A, et al. Among authors: eliopoulos ag. Blood. 1999 May 1;93(9):2999-3007. Blood. 1999. PMID: 10216096 Free article.

2

The role of the CD40 pathway in the pathogenesis and treatment of cancer.

Eliopoulos AG, Young LS. Eliopoulos AG, et al. Curr Opin Pharmacol. 2004 Aug;4(4):360-7. doi: 10.1016/j.coph.2004.02.008. Curr Opin Pharmacol. 2004. PMID: 15251129 Review.

3

Prolonged phenotypic, functional, and molecular change in group I Burkitt lymphoma cells on short-term exposure to CD40 ligand.

Baker MP, Eliopoulos AG, Young LS, Armitage RJ, Gregory CD, Gordon J. Baker MP, et al. Among authors: eliopoulos ag. Blood. 1998 Oct 15;92(8):2830-43. Blood. 1998. PMID: 9763568 Free article.

4

Involvement of ceramide and JNK in CD40-mediated growth inhibition.

Armour CA, Eliopoulos AG, Dawson CW, Young LS, Wakelam MJ. Armour CA, et al. Among authors: eliopoulos ag. Biochem Soc Trans. 1997 Nov;25(4):S588. doi: 10.1042/bst025s588. Biochem Soc Trans. 1997. PMID: 9450016 No abstract available.

5

CD40 and epithelial cells: across the great divide.

Young LS, Eliopoulos AG, Gallagher NJ, Dawson CW. Young LS, et al. Among authors: eliopoulos ag. Immunol Today. 1998 Nov;19(11):502-6. doi: 10.1016/s0167-5699(98)01340-1. Immunol Today. 1998. PMID: 9818543 Review.

6

CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily.

Eliopoulos AG, Davies C, Knox PG, Gallagher NJ, Afford SC, Adams DH, Young LS. Eliopoulos AG, et al. Mol Cell Biol. 2000 Aug;20(15):5503-15. doi: 10.1128/MCB.20.15.5503-5515.2000. Mol Cell Biol. 2000. PMID: 10891490 Free PMC article.

7

CD40 activation in epithelial ovarian carcinoma cells modulates growth, apoptosis, and cytokine secretion.

Gallagher NJ, Eliopoulos AG, Agathangelo A, Oates J, Crocker J, Young LS. Gallagher NJ, et al. Among authors: eliopoulos ag. Mol Pathol. 2002 Apr;55(2):110-20. doi: 10.1136/mp.55.2.110. Mol Pathol. 2002. PMID: 11950960 Free PMC article.

8

Inhibition of metalloproteinase cleavage enhances the cytotoxicity of Fas ligand.

Knox PG, Milner AE, Green NK, Eliopoulos AG, Young LS. Knox PG, et al. Among authors: eliopoulos ag. J Immunol. 2003 Jan 15;170(2):677-85. doi: 10.4049/jimmunol.170.2.677. J Immunol. 2003. PMID: 12517928

9

NF-kappaB overrides the apoptotic program of TNF receptor 1 but not CD40 in carcinoma cells.

Davies CC, Bem D, Young LS, Eliopoulos AG. Davies CC, et al. Among authors: eliopoulos ag. Cell Signal. 2005 Jun;17(6):729-38. doi: 10.1016/j.cellsig.2004.10.014. Epub 2004 Dec 7. Cell Signal. 2005. PMID: 15722197

10

CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator.

Eliopoulos AG, Dawson CW, Mosialos G, Floettmann JE, Rowe M, Armitage RJ, Dawson J, Zapata JM, Kerr DJ, Wakelam MJ, Reed JC, Kieff E, Young LS. Eliopoulos AG, et al. Oncogene. 1996 Nov 21;13(10):2243-54. Oncogene. 1996. PMID: 8950992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters